1. Home
  2. STVN vs HLNE Comparison

STVN vs HLNE Comparison

Compare STVN & HLNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STVN
  • HLNE
  • Stock Information
  • Founded
  • STVN 1949
  • HLNE 1991
  • Country
  • STVN Italy
  • HLNE United States
  • Employees
  • STVN N/A
  • HLNE N/A
  • Industry
  • STVN Containers/Packaging
  • HLNE Investment Managers
  • Sector
  • STVN Consumer Discretionary
  • HLNE Finance
  • Exchange
  • STVN Nasdaq
  • HLNE Nasdaq
  • Market Cap
  • STVN 6.2B
  • HLNE 5.9B
  • IPO Year
  • STVN 2021
  • HLNE 2017
  • Fundamental
  • Price
  • STVN $22.96
  • HLNE $153.71
  • Analyst Decision
  • STVN Buy
  • HLNE Hold
  • Analyst Count
  • STVN 4
  • HLNE 7
  • Target Price
  • STVN $25.13
  • HLNE $160.43
  • AVG Volume (30 Days)
  • STVN 341.4K
  • HLNE 366.3K
  • Earning Date
  • STVN 08-05-2025
  • HLNE 08-05-2025
  • Dividend Yield
  • STVN 0.27%
  • HLNE 1.40%
  • EPS Growth
  • STVN 6.78
  • HLNE 18.07
  • EPS
  • STVN 0.57
  • HLNE 5.15
  • Revenue
  • STVN $1,344,798,591.00
  • HLNE $692,190,000.00
  • Revenue This Year
  • STVN $8.24
  • HLNE $6.15
  • Revenue Next Year
  • STVN $10.38
  • HLNE $15.05
  • P/E Ratio
  • STVN $40.05
  • HLNE $29.98
  • Revenue Growth
  • STVN 5.28
  • HLNE 10.66
  • 52 Week Low
  • STVN $17.12
  • HLNE $124.10
  • 52 Week High
  • STVN $28.00
  • HLNE $203.72
  • Technical
  • Relative Strength Index (RSI)
  • STVN 47.98
  • HLNE 50.72
  • Support Level
  • STVN $21.51
  • HLNE $152.67
  • Resistance Level
  • STVN $23.72
  • HLNE $155.80
  • Average True Range (ATR)
  • STVN 0.84
  • HLNE 3.83
  • MACD
  • STVN 0.09
  • HLNE -0.24
  • Stochastic Oscillator
  • STVN 65.77
  • HLNE 48.24

About STVN Stevanato Group S.p.A.

Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.

About HLNE Hamilton Lane Incorporated

Hamilton Lane Inc is a private market investment solutions provider in the United States. It works with its clients to conceive, structure, build out, manage and monitor portfolios of private markets funds and direct investments, and it helps them access a set of such investment opportunities around the world. The company offers a range of investment solutions across a range of private markets, including private equity, private credit, real estate, infrastructure, natural resources, growth equity, venture capital and impact. The company generate revenues mainly from management and advisory fees.

Share on Social Networks: